← Back to Analyst Consensus 
LCTX Buy
Lineage Cell Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jul 14, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 4, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Apr 28, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Mar 25, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Mar 24, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 6, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Feb 9, 2026 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Nov 25, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Nov 24, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Aug 27, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Aug 14, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Aug 5, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Jun 23, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Jun 23, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Mar 14, 2025 | B. Riley Securities | maintain | Buy → Buy | $3 | 54% |
| Mar 11, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Mar 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Feb 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Feb 11, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Jan 31, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $9 | 44% |
| Jan 10, 2025 | Maxim Group | maintain | Buy → Buy | $3 | 42% |
| Jan 3, 2025 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Dec 4, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Nov 20, 2024 | D. Boral Capital | maintain | Buy → Buy | $2 | 34% |
| Nov 18, 2024 | D. Boral Capital | initiate | — → Buy | $3 | 34% |
| Aug 20, 2024 | Craig-Hallum | initiate | — → Buy | $4 | 54% |
| May 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Mar 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Feb 5, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $6 | 50% |
| Aug 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 25, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $6 | 50% |
| Jul 24, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| May 12, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Apr 26, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $7 | 44% |
| Mar 10, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $7 | 44% |
| Nov 2, 2022 | Baird | initiate | — → Outperform | $5 | 55% |
| Jun 14, 2022 | B. Riley Securities | initiate | — → Buy | $4 | 54% |
| Aug 19, 2021 | Noble Capital Markets | initiate | — → Outperform | $8 | 63% |
| Mar 31, 2021 | Cantor Fitzgerald | initiate | — → Overweight | $6 | 50% |
| Sep 17, 2020 | Noble Capital Markets | initiate | — → Outperform | $0 | 63% |
Price Target Trend
Apr 25, 2026 Oct 26, 2026
EPS Estimates
+1y —
0q —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days